PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma

21Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The synthesis of serine from glucose is a key metabolic pathway supporting cellular proliferation in healthy and malignant cells. Despite this, the role that this aspect of metabolism plays in germinal center biology and pathology is not known. Here, we performed a comprehensive characterization of the role of the serine synthesis pathway in germinal center B cells and lymphomas derived from these cells. We demonstrate that upregulation of a functional serine synthesis pathway is a metabolic hallmark of B cell activation and the germinal center reaction. Inhibition of phosphoglycerate dehydrogenase (PHGDH), the first and rate-limiting enzyme in this pathway, led to defective germinal formation and impaired high-affinity antibody production. In addition, overexpression of enzymes involved in serine synthesis was a characteristic of germinal center B cell–derived lymphomas, with high levels of expression being predictive of reduced overall survival in diffuse large B cell lymphoma. Inhibition of PHGDH induced apoptosis in lymphoma cells, reducing disease progression. These findings establish PHGDH as a critical player in humoral immunity and a clinically relevant target in lymphoma.

Cite

CITATION STYLE

APA

D’Avola, A., Legrave, N., Tajan, M., Chakravarty, P., Shearer, R. L., King, H. W., … Riches, J. C. (2022). PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma. Journal of Clinical Investigation, 132(9). https://doi.org/10.1172/JCI153436

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free